Michael Böhm

Showing 1-14 of 14 articles

Interventions for hypertension

Prioritized Endpoints for Device-Based Hypertension Trials: the Win Ratio Methodology

Kandzari D, Hickey G, Pocock S, Weber MA, Böhm M, Cohen SA, Fahy M, Lamberti G, Mahfoud F

November 24, 2020 | 10.4244/EIJ-D-20-01090

Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation

Townsend R, Walton A, Hettrick D, Hickey G, Weil J, Sharp A, Blankestijn P, Böhm M, Mancia G

May 20, 2020 | 10.4244/EIJ-D-19-00902

Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial

Scheller B, Ohlow M, Ewen S, Kische S, Rudolph T, Clever Y, Wagner A, Richter S, El-Garhy M, Böhm M, Degenhardt R, Mahfoud F, Lauer B

April 17, 2020 | 10.4244/EIJ-D-19-00723

Other

Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension

Lauder L, Ewen S, Tzafriri A, Edelman E, Lüscher T, Blankestijn P, Dörr O, Schlaich M, Sharif F, Voskuil M, Zeller T, Ukena C, Scheller B, Böhm M, Mahfoud F

May 20, 2018 | 10.4244/EIJ-D-18-00112

TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

Lauten A, Figulla HR, Möllmann H, Holzhey D, Kotting J, Beckmann A, Veit C, Cremer J, Kuck K, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Welz A, Mohr F, Hamm C

November 20, 2014 | 10.4244/EIJV10I7A145

Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation

Lenski D, Kindermann I, Lenski M, Ukena C, Bunz M, Mahfoud F, Böhm M

October 25, 2013 | 10.4244/EIJV9I6A114

Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry

Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe U, Kintscher U, Narkiewicz K, Negoita M, Ruilope L, Rump L, Schlaich M, Schmieder R, Sievert H, Weil J, Williams B, Zeymer U, Mancia G

August 23, 2013 | 10.4244/EIJV9I4A78

Response and non-response to renal denervation: who is the ideal candidate?

Ukena C, Cremers B, Ewen S, Böhm M, Mahfoud F

May 21, 2013 | 10.4244/EIJV9SRA10

Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias

Ukena C, Mahfoud F, Linz D, Böhm M, Neuberger H-R

May 21, 2013 | 10.4244/EIJV9SRA19

Expanding the indication spectrum: renal denervation in diabetes

Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka P, Cremers B, Böhm M

May 21, 2013 | 10.4244/EIJV9SRA20

Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure

Böhm M, Ewen S, Linz D, Reil J-C, Schirmer S, Ukena C, Mahfoud F

May 21, 2013 | 10.4244/EIJV9SRA21

First-in-human experience: percutaneous renal denervation through a false lumen fenestration in aortic dissection type B

Ewen S, Mahfoud F, Böhm M

January 18, 2013 | 10.4244/EIJV8I9A170

Paclitaxel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study

Fischer D, Scheller B, Schäfer A, Klein G, Böhm M, Clever Y, Cremers B

August 24, 2012 | 10.4244/EIJV8I4A71

Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells

Clever Y, Cremers B, KrauÃŸ B, Böhm M, Speck U, Laufs U, Scheller B

May 17, 2011

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers